Buy HUMULIN R 100IU VIAL (INSULIN) Online

Overview: HUMULIN R 100IU VIAL is a pharmaceutical product containing regular human insulin, manufactured by Lilly. It is available in the form of a vial containing 10 mL of insulin solution. This product is primarily used to manage blood sugar levels in patients with diabetes mellitus.

Detailed Description:

1. Active Substance: HUMULIN R contains regular human insulin, which is identical to the insulin produced by the human pancreas. Insulin is a hormone essential for the regulation of glucose metabolism. In individuals with diabetes, either the body does not produce enough insulin (Type 1 diabetes) or does not effectively use insulin (Type 2 diabetes).

2. Form and Packaging: Each pack of HUMULIN R includes one vial, with each vial containing 10 mL of insulin solution. The vial is typically made of glass and is sealed with a rubber stopper. The packaging ensures the integrity and sterility of the insulin until use.

3. Indications: HUMULIN R is prescribed for the management of diabetes mellitus to help control blood sugar levels. It is commonly used in combination with intermediate- or long-acting insulins to achieve optimal glycemic control throughout the day. Regular human insulin acts faster than intermediate-acting insulins but has a shorter duration of action.

4. Administration: This insulin is administered via subcutaneous injection. The dosage and administration schedule are determined by the healthcare provider based on the patient’s individual needs, blood glucose monitoring results, and other factors influencing diabetes management.

5. Storage: HUMULIN R should be stored under refrigeration between 36°F to 46°F (2°C to 8°C). It should not be frozen. Once in use, the vial can be kept at room temperature (below 86°F or 30°C) for up to 28 days, after which it should be discarded.

6. Precautions and Warnings:

• Careful monitoring of blood glucose levels is essential during treatment with HUMULIN R to adjust insulin doses as necessary.
• Hypoglycemia (low blood sugar) and hyperglycemia (high blood sugar) may occur with insulin therapy. Patients should be educated on recognizing and managing these conditions.
• Patients with known hypersensitivity to insulin or any of the product’s components should not use HUMULIN R.

7. Adverse Reactions: Common side effects may include hypoglycemia, injection site reactions (such as redness, swelling, or itching), weight gain, and allergic reactions. Patients should report any unexpected or severe reactions to their healthcare provider.

8. Manufacturer: HUMULIN R is manufactured by Lilly, a globally recognized pharmaceutical company known for its commitment to producing high-quality medications.